NR2C2 and pituitary tumor: The past few years have brought considerable progress in the knowledge of molecular changes in ACTH-secreting pituitary tumors, e.g., the involvement of epidermal growth factor [18] and orphan nuclear receptor TR4 [19], differing miRNA patterns [20], and, lately, also the presence of somatic mutations [21].